CHINA PHARMA HOLDINGS, INC. Provision for Other Credit Losses
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Provision for Other Credit Losses of $779 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProvisionForOtherCreditLosses · last filed 2026-08-14
- CHINA PHARMA HOLDINGS, INC. provision for other credit losses for the quarter ending 2025-12-31 was $13.70M.
- CHINA PHARMA HOLDINGS, INC. provision for other credit losses for the quarter ending 2025-09-30 was -$13.70M.
- CHINA PHARMA HOLDINGS, INC. provision for other credit losses for fiscal 2025 was -$4.03K, a 170.66% decline from fiscal 2024.
- CHINA PHARMA HOLDINGS, INC. provision for other credit losses for fiscal 2024 was $5.70K.
| Period end | Provision for Other Credit Losses 3 month | Provision for Other Credit Losses 6 month | Provision for Other Credit Losses 9 month | Provision for Other Credit Losses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $779.00 10-Q · filed 2026-08-14 | |||
| 2025-12-31 | $13.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | -$4.03K derived: sum of 2 quarters · filed 2026-04-01 | -$4.03K 10-K · filed 2026-04-01 | |
| 2025-09-30 | -$13.70M 10-Q · filed 2025-11-12 | -$13.70M 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | $709.00 10-Q · filed 2026-08-14 | |||
| 2024-12-31 | $5.70K 10-K · filed 2026-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |